135 related articles for article (PubMed ID: 3875469)
1. [Osteocalcin, a marker in diseases with elevated bone metabolism].
Stracke H; Schatz C; Pralle H; Ullmann J; Schatz H
Dtsch Med Wochenschr; 1985 Sep; 110(38):1442-6. PubMed ID: 3875469
[TBL] [Abstract][Full Text] [Related]
2. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
Motz W
Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
[TBL] [Abstract][Full Text] [Related]
3. [Osteocalcin].
Galli M; Caniggia M
Minerva Med; 1984 Nov; 75(42):2489-501. PubMed ID: 6334818
[TBL] [Abstract][Full Text] [Related]
4. Serum osteocalcin levels in normal subjects and patients with primary hyperparathyroidism.
Ljunghall S; Hällgren R; Rastad J
Exp Clin Endocrinol; 1985 Dec; 86(2):218-22. PubMed ID: 3879222
[TBL] [Abstract][Full Text] [Related]
5. Serum osteocalcin, bone alkaline phosphatase isoenzyme and plasma tartrate resistant acid phosphatase in patients on chronic maintenance hemodialysis.
Stĕpán JJ; Lachmanová J; Straková M; Pacovský V
Bone Miner; 1987 Nov; 3(2):177-83. PubMed ID: 3509796
[TBL] [Abstract][Full Text] [Related]
6. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
7. Serum osteocalcin (BGP) in tumor-associated hypercalcemia.
Body JJ; Cleeren A; Pot M; Borkowski A
J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743
[TBL] [Abstract][Full Text] [Related]
8. [Bone turnover markers in tumor pathology with bone involvement].
Napal Lecumberri J; Amado Señarís JA; Pesquera C; Riancho JA; González Macías J
Med Clin (Barc); 1990 Apr; 94(13):487-9. PubMed ID: 2355762
[TBL] [Abstract][Full Text] [Related]
9. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
10. Influence of sex and age on biochemical bone metabolism parameters.
Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
[TBL] [Abstract][Full Text] [Related]
11. Impact of calcineurin inhibitors on bone metabolism in primary kidney transplant patients.
Bozkaya G; Nart A; Uslu A; Onman T; Aykas A; Doğan M; Karaca B
Transplant Proc; 2008; 40(1):151-5. PubMed ID: 18261573
[TBL] [Abstract][Full Text] [Related]
12. Bone alkaline phosphatase isoenzyme and urinary hydroxyproline in healthy subjects, patients with osteolytic metastases, and patients with primary hyperparathyroidism.
Stĕpán JJ; Mikulecký M; Bek V; Broulík P; Pacovský V
Neoplasma; 1989; 36(4):495-501. PubMed ID: 2770935
[TBL] [Abstract][Full Text] [Related]
13. Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age.
Lepage OM; Marcoux M; Tremblay A
Can J Vet Res; 1990 Apr; 54(2):223-6. PubMed ID: 2357658
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting.
Slovik DM; Gundberg CM; Neer RM; Lian JB
J Clin Endocrinol Metab; 1984 Aug; 59(2):228-30. PubMed ID: 6610686
[TBL] [Abstract][Full Text] [Related]
15. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism.
Stĕpán JJ; Presl J; Broulík P; Pacovský V
J Clin Endocrinol Metab; 1987 May; 64(5):1079-82. PubMed ID: 3031119
[TBL] [Abstract][Full Text] [Related]
16. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
Charles P; Poser JW; Mosekilde L; Jensen FT
J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
[TBL] [Abstract][Full Text] [Related]
17. [Different behavior of bone turnover markers in endocrine (extrinsic) and structural (intrinsic) osteopathies].
Napal J; Amado JA; Riancho JA; Freijanes J; Pesquera C; González-Macías J
Med Clin (Barc); 1990 Mar; 94(8):294-8. PubMed ID: 2342391
[TBL] [Abstract][Full Text] [Related]
18. Serum osteocalcin concentrations in Paget's disease of bone.
Wilkinson MR; Wagstaffe C; Delbridge L; Wiseman J; Posen S
Arch Intern Med; 1986 Feb; 146(2):268-71. PubMed ID: 3484940
[TBL] [Abstract][Full Text] [Related]
19. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery.
Minisola S; Scarnecchia L; Scarda A; Bigi F; Tabolli S; Valtorta C; Mazzuoli G
Miner Electrolyte Metab; 1988; 14(4):201-7. PubMed ID: 3264876
[TBL] [Abstract][Full Text] [Related]
20. [Osteocalcin, marker of bone metabolism].
Peretz A
Bull Mem Acad R Med Belg; 1993; 148(1-2):90-6; discussion 97-9. PubMed ID: 8111341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
